U.S. flag

An official website of the United States government

NM_000379.4(XDH):c.3847C>T (p.Arg1283Ter) AND Xanthinuria type II

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Aug 27, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001387749.7

Allele description [Variation Report for NM_000379.4(XDH):c.3847C>T (p.Arg1283Ter)]

NM_000379.4(XDH):c.3847C>T (p.Arg1283Ter)

Gene:
XDH:xanthine dehydrogenase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2p23.1
Genomic location:
Preferred name:
NM_000379.4(XDH):c.3847C>T (p.Arg1283Ter)
HGVS:
  • NC_000002.12:g.31337745G>A
  • NG_008871.2:g.82001C>T
  • NM_000379.4:c.3847C>TMANE SELECT
  • NP_000370.2:p.Arg1283Ter
  • NC_000002.11:g.31560611G>A
  • NG_008871.1:g.82001C>T
  • NM_000379.3:c.3847C>T
Protein change:
R1283*
Links:
dbSNP: rs751921838
NCBI 1000 Genomes Browser:
rs751921838
Molecular consequence:
  • NM_000379.4:c.3847C>T - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Name:
Xanthinuria type II
Synonyms:
Xanthinuria type 2; Xanthine dehydrogenase and aldehyde oxidase combined deficiency of; XDH and AOX dual deficiency
Identifiers:
MONDO: MONDO:0011346; MedGen: C1863688; Orphanet: 3467; OMIM: 603592

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001588459Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Aug 27, 2023)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Xanthinuria type I with a novel mutation of xanthine dehydrogenase.

Tanaka K, Kanazawa I, Yamasaki H, Hasegawa H, Ichida K, Sugimoto T.

Am J Med Sci. 2015 Aug;350(2):155-6. doi: 10.1097/MAJ.0000000000000498. No abstract available.

PubMed [citation]
PMID:
26110747

Identification of two mutations in human xanthine dehydrogenase gene responsible for classical type I xanthinuria.

Ichida K, Amaya Y, Kamatani N, Nishino T, Hosoya T, Sakai O.

J Clin Invest. 1997 May 15;99(10):2391-7.

PubMed [citation]
PMID:
9153281
PMCID:
PMC508078
See all PubMed Citations (3)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001588459.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 335758). This premature translational stop signal has been observed in individual(s) with xanthinuria type Ι (PMID: 26110747). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change creates a premature translational stop signal (p.Arg1283*) in the XDH gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in XDH are known to be pathogenic (PMID: 9153281).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024